UBS analyst Marc Goodman reiterated a Buy rating and boosted his price target on Allergen (NYSE: AGN) to $366.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE